The DynaChip technology was developed as a result of a collaboration between German array developer Clondiag, a unit of Inverness Medical Innovations, and Invitrogen
Invitrogen recently introduced its DynaChip HLA antibody analysis system.
DynaChip technology utilises a highly automated microarray platform to detect antibody reaction to specific HLA antigens.
The DynaChip technology was developed as a result of a collaboration between German array developer Clondiag, a unit of Inverness Medical Innovations, and Invitrogen.
Up to 96 tests can be performed at the same time in a fully automated manner, with each test including an array of proteins.
The system includes software that allows for rapid analysis of results.
The DynaChip system is currently available in Europe under a CE mark and is available for 'research use only' in the United States.
It is in the process of obtaining FDA 510K clearance in the United States.
